HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Axe Innovates To Give Men “Girl-Approved” Hair, New Edge In “Mating Game”

This article was originally published in The Rose Sheet

  • News

Executive Summary

Unilever's Axe brand is marketing its new men's hair-care line as the answer to hair problems men do not even know they have

You may also be interested in...



Unilever, MTV Campaign For Axe Hair Is Unprecedented, Parties Say

Unilever's Axe men's grooming brand is being promoted with two innovative campaigns - one representing its largest multimedia effort yet - that reflect the brand's characteristically edgy positioning

Unilever, MTV Campaign For Axe Hair Is Unprecedented, Parties Say

Unilever's Axe men's grooming brand is being promoted with two innovative campaigns - one representing its largest multimedia effort yet - that reflect the brand's characteristically edgy positioning

P&G’s Gillette Announces Line Extensions, Stays Abreast With Unilever’s Axe

Gillette's growth strategy continues to mirror that formula for success provided by competitor Axe since 2002 when the brand elevated the "game" of teenaged American males by launching its fragranced body sprays in the U.S

Table

View full table

Tags:
Latest Headlines

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

See All
UsernamePublicRestriction

Register

RS015831

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By